The role of radiofrequency ablation in the management of Barrett's esophagus.
Studies in the last several years have consistently shown radiofrequency ablation (RFA) to be effective, safe, and well tolerated in the treatment of nondysplastic and dysplastic Barrett's esophagus (BE). The results found at academic medical centers have been reproduced in the community setting. RFA provides a safe and cost-effective alternative to surgery or surveillance in the management of high-grade dysplasia (HGD). RFA should be given serious consideration as first-line therapy for HGD. This article reviews the evidence behind RFA to differentiate it from other management strategies in terms of efficacy, durability, safety, tolerability, and cost-effectiveness. The role of RFA in the management of BE is described, including endoscopic resection. Future directions are identified for research that will help to better define the role of RFA in the management of BE.
GI Outcomes Training Program, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
William J
WJ
Bulsiewicz
Nicholas J
NJ
Shaheen
D001471:Barrett Esophagus / Q000473:pathology / Q000601:surgery*; D017115:Catheter Ablation / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D016629:Esophagectomy; D004947:Esophagus / Q000473:pathology / Q000601:surgery*; D006801:Humans; D011230:Precancerous Conditions / Q000473:pathology / Q000601:surgery*